A citation-based method for searching scientific literature

Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn, Melinda Telli, Stephen M Pochebit, Georgios Lypas, Judy E Garber. Breast Cancer Res Treat 2012
Times Cited: 88

List of co-cited articles
900 articles co-cited >1

Times Cited
  Times     Co-cited

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations.
J R F Wilson, A C Bateman, H Hanson, Q An, G Evans, N Rahman, J L Jones, D M Eccles. J Med Genet 2010

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014

P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M G Dondon, B Bressac-de Paillerets,[...]. Br J Cancer 2000

2009 version of the Chompret criteria for Li Fraumeni syndrome.
Julie Tinat, Gaelle Bougeard, Stéphanie Baert-Desurmont, Stéphanie Vasseur, Cosette Martin, Emilie Bouvignies, Olivier Caron, Brigitte Bressac-de Paillerets, Pascaline Berthet, Catherine Dugast,[...]. J Clin Oncol 2009

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
J M Birch, A L Hartley, K J Tricker, J Prosser, A Condie, A M Kelsey, M Harris, P H Jones, A Binchy, D Crowther. Cancer Res 1994

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M McCuaig, Susan R Armel, Ana Novokmet, Ophira M Ginsburg, Rochelle Demsky, Steven A Narod, David Malkin. Fam Cancer 2012

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
K E Nichols, D Malkin, J E Garber, J F Fraumeni, F P Li. Cancer Epidemiol Biomarkers Prev 2001

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011

Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Judy Mouchawar, Christopher Korch, Tim Byers, Todd M Pitts, Efang Li, Margaret R E McCredie, Graham G Giles, John L Hopper, Melissa C Southey. Cancer Res 2010

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016

Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
Steve Heymann, Suzette Delaloge, Arslane Rahal, Olivier Caron, Thierry Frebourg, Lise Barreau, Corinne Pachet, Marie-Christine Mathieu, Hugo Marsiglia, Céline Bourgier. Radiat Oncol 2010

Germline mutations in the TP53 gene.
R A Eeles. Cancer Surv 1995

Multiple primary cancers in families with Li-Fraumeni syndrome.
M Hisada, J E Garber, C Y Fung, J F Fraumeni, F P Li. J Natl Cancer Inst 1998

High frequency of de novo mutations in Li-Fraumeni syndrome.
K D Gonzalez, C H Buzin, K A Noltner, D Gu, W Li, D Malkin, S S Sommer. J Med Genet 2009

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.
Rebecca C Fitzgerald, Richard Hardwick, David Huntsman, Fatima Carneiro, Parry Guilford, Vanessa Blair, Daniel C Chung, Jeff Norton, Krishnadath Ragunath, J Han Van Krieken,[...]. J Med Genet 2010

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.
Nicholas Hearle, Valérie Schumacher, Fred H Menko, Sylviane Olschwang, Lisa A Boardman, Johan J P Gille, Josbert J Keller, Anne Marie Westerman, Rodney J Scott, Wendy Lim,[...]. Clin Cancer Res 2006

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Shih-Jen Hwang, Guillermina Lozano, Christopher I Amos, Louise C Strong. Am J Hum Genet 2003

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
Patricia Wong, Sigitas J Verselis, Judy E Garber, Katherine Schneider, Lisa DiGianni, David H Stockwell, Frederick P Li, Sapna Syngal. Gastroenterology 2006

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V Tavtigian, Pierre Hainaut, Magali Olivier. Hum Mutat 2007

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
Michelle G Rath, Serena Masciari, Rebecca Gelman, Alexander Miron, Penelope Miron, Kathleen Foley, Andrea L Richardson, Ian E Krop, Sigitas J Verselis, Deborah A Dillon,[...]. Breast Cancer Res Treat 2013

Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
J M Birch, R D Alston, R J McNally, D G Evans, A M Kelsey, M Harris, O B Eden, J M Varley. Oncogene 2001

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
Uri Tabori, Sonia Nanda, Harriet Druker, Jodi Lees, David Malkin. Cancer Res 2007

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
K A Schrader, S Masciari, N Boyd, C Salamanca, J Senz, D N Saunders, E Yorida, S Maines-Bandiera, P Kaurah, N Tung,[...]. J Med Genet 2011

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.